Aqueous extract isolated from Platycodon grandiflorum elicits the release of nitric oxide and tumor necrosis factor-α from murine macrophages

International Immunopharmacology

Volumn 1, Issue 6, 2001, Pages 1141-1151

  Choi, Chul Yung ^a   Kim, Ji Young ^a   Kim, Young Sup ^b   Chung, Young Chul ^c   Seo, Jong Kwon ^d   Jeong, Hye Gwang ^a  

^a Chosun University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c Chinju College   (South Korea)

^d Jangsaeng Doraji Co Ltd   (South Korea)

Author keywords

Macrophages; Nitric oxide; Platycodon grandiflorum; Tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENTARY DNA; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; PLATYCODON GRANDIFLORUM EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HERBAL MEDICINE; IMMUNOMODULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BETA-GALACTOSIDASE; FEMALE; IMMUNOASSAY; LIMULUS TEST; LUCIFERASES; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRITES; PLANT EXTRACTS; PLANT ROOTS; PLANTS, MEDICINAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0343832081     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00047-9     Document Type: Article

References (35)

1. Xie O.-W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M.et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
2. Nijkamp F., Folkerts G. Nitric oxide: initiator and modulator. Clin. Exp. Allergy. 27:1997;347-350.
3. Duerksen-Hughes P.J., Day D., Laster S.M., Zachariades N.A., Aquino L., Gooding L.R. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40 transformed cells by activated macrophages. J. Immunol. 149:1992;2114-2122.
4. Stuehr D.J., Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1989;1543-1555.
5. Farias-Eisner R., Sherman M.P., Aerberhard E., Chaudhuri G. Nitric oxide is an important mediator of tumoricidal activity in vivo. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9407-9411.
6. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. J. Biol. Chem. 268:1993;1908-1913.
7. Nicotera P., Brune P., Bagetta G. Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol. Sci. 18:1997;189-190.
8. Xie K., Huang S., Dong Z., Juang S.-H., Gutman M.et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181:1995;1333-1343.
9. Balkwill F.R., Maylor M.S., Malik S. Tumor necrosis factor as an anticancer agent. Eur. J. Cancer. 26:1990;641-644.
10. Gorelik L., Bar-Dagan Y., Mokyr M.B. Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer spleenic cells. J. Immunol. 156:1996;4298-4308.
11. Lasek W., Feleszko W., Golab J., Stoklosa T., Marczak M.et al. Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor a in mice. Cancer Immunol. Immunother. 45:1997;100-108.
12. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
13. Willett W.C. Diet and health: what should we eat? Science. 264:1994;532-537.
14. Hamuro J., Kikuchi T., Takatsuki F., Suzuki M. Cancer cell progression and chemoimmunotherapy dual effects in the induction of resistance to therapy. Br. J. Cancer. 73:1996;465-471.
15. Lee E.B. Pharmacological studies on Platycodon grandiflorum A. DC: IV. A comparison of experimental pharmacological effects of crude platycodin with clinical indications of platycodi radix. Yakugaku Zasshi. 93:1973;1188-1194.
16. Lee E.B. Pharmacological activities of crude platycodin. J. Pharm. Soc. Korea. 19:1975;164-176.
17. Kim K.S., Ezaki O., Ikemoto S., Itakura H. Effects of Platycodon grandiflorum feeding on serum and liver lipid concentrations in rats with diet-induced hyperlipidemia. J. Nutr. Sci. Vitaminol. 41:1995;485-491.
18. Tada A., Kaneiwa Y., Shoji J., Shibata S. Studies on the saponins of the root of Platycodon grandiflornm. A. DE CANDOLLE: I. Isolation and the structure of platycodin-D. Chem. Pharm. Bull. 23:1975;2965-2972.
19. Saeki T., Koike K., Nikaido T. A comparative study on commercial, botanical gardens and wild samples of the roots of Platycodon grandiflorum by HPLC analysis. Planta Med. 65:1999;428-431.
20. Takagi K., Lee E.B. Pharmacological studies on Platycodon grandiflorum A. DC. Activities of crude platycodin on respiratory and circulatory systems and its other pharmacological activities. Yakugaku Zasshi. 92:1972;969-973.
21. Kubo M., Nagao T., Matsuda H., Namba K. Immune pharmacological studies on platycodi radix (I): effect on the phagocytosis in mouse. Shoyakugaku Zasshi. 40:1986;367-374.
22. Nagao T., Matsuda H., Namba K., Kubo M. Immune pharmacological studies on platicodi radix (II): antitumor activity of inulin from platicodi radix. Shoyakugaku Zasshi. 40:1986;375-380.
23. Kim Y.S., Lee B.E., Kim K.J., Lee Y.T., Gho K.B., Chung Y.C. Antitumor and immunomodulatory activities of the Platycodon grandiflorum cultivated for more than 20 years. Yakhak Hoeji. 42:1998;382-387.
24. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
25. Hibbs J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
26. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 82:1985;7738-7742.
27. Manthey C.L., Brandes M.E., Perera P.U., Vogel S.N. Taxol increase steady-state levels of lipopolysaccharide-inducible gene and protein-tyrosine phosphorylation in murine macrophages. J. Immunol. 149:1992;2459-2465.
28. Martin J.H., Edwards S.W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J. Immunol. 150:1993;3478-3486.
29. Poderoso J.J., Carreras M.C., Schopfer F., Lisdero C.L., Riobo N.A., Giulivi C.et al. The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance. Free Radical Biol. Med. 16:1999;925-935.
30. Kato M., Hirose K., Hakozaki M., Ohno M., Saito Y.et al. Induction of expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol. Immunother. 40:1995;152-156.
31. Leung M.Y.K., Fung K.P., Choy Y.M. The isolation and characterization of an immunoinodulatory and anti-tumor polysaccharide preparation from Flummulinu velutipes. Immunopharmacology. 35:1997;255-263.
32. Ito H., Shimura K., Itoh H., Kawade M. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blatei (Iwade strain 101) "Hime-matsutake" and its mechanism in tumor-bearing mice. Anti-Cancer Res. 17:1997;277-284.
33. Marcinkiewicz J., Grabowska A., Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:1995;947-951.
34. Klebanoff S.J. Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radical Biol. Med. 14:1993;351-360.
35. Yamauchi N., Kuriyama H., Watanabe N., Neda H., Maeda M., Niitsu Y. Intracellular hydroxy radical production induced by recombinant human tumor necrosis factor and it implication in the killing of tumor cells in vitro. Cancer Res. 49:1989;1671-1675.